Remember, rest is just as important as activitybalance your workouts with sufficient recovery to avoid burnout and injury
The advent of a dedicated treatment option approved by the Food and Drug Administration (US FDA) for MASH offers significant opportunities and expert guidance exists on the implementation within the US healthcare system 6
Potential pancreatitis risk : As with other GLP-1-based therapies, there is a theoretical concern regarding pancreatitis, though causality has not been firmly established in trials to date
Aryee, M
Altintas Dogan et al 75 experiment found that liraglutide significantly reduced body weight, decreased inflammatory markers such as IL-6 and MCP-1, increased exertional spirometry (FVC) and carbon monoxide diffusion capacity, and improved COPD assessment test scores, but no significant improvement in FEV1, FEV1/FVC, or 6-minute walk tests, suggesting the possibility that GLP-1RA may reduce inflammatory responses, improve lung function, and mitigate the degree of impaired health in patients with COPD